Search Results - "Silva, Adriano Gonçalves E"
-
1
Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program
Published in Therapeutic advances in medical oncology (2021)“…Background: Erdafitinib is the first targeted therapy approved for the treatment of patients with metastatic urothelial carcinoma (mUC). Approval was based on…”
Get full text
Journal Article -
2
Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries
Published in JCO global oncology (01-04-2021)“…To present a summary of the recommendations for the treatment and follow-up for the biochemical recurrence of castration-resistant prostate cancer (PCa) as…”
Get full text
Journal Article -
3
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
Published in Journal of cancer research and clinical oncology (01-07-2020)“…Purpose The outcome of RCC has improved considerably in the last few years, and the treatment options have increased. LACOG-GU and LARCG held a consensus…”
Get full text
Journal Article -
4
Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN Gene
Published in Case reports in oncology (01-01-2022)“…Werner’s syndrome is caused by the inactivation of both WRN alleles and is characterized by premature aging and increased risk of neoplasms, especially those…”
Get full text
Journal Article -
5
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery
Published in Therapeutic Advances in Urology (2019)“…Background: Renal cell cancer (RCC) is one of the 10 most common cancers in the world, and its incidence is increasing, whereas mortality is declining only in…”
Get full text
Book Review Journal Article -
6
Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil
Published in Clinical genitourinary cancer (01-04-2023)“…Non-metastatic, castration-resistant prostate cancer (nmCRPC) is an important clinical stage of prostate cancer, prior to morbidity and mortality from clinical…”
Get full text
Journal Article -
7
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
Published in Journal of cancer research and clinical oncology (09-04-2024)“…Purpose Renal cell carcinoma is an aggressive disease with a high mortality rate. Management has drastically changed with the new era of immunotherapy, and…”
Get full text
Journal Article -
8
Dysembrioplastic neuroepithelial tumor: Cytological diagnosis by intraoperative smear preparation
Published in Diagnostic cytopathology (01-02-2002)“…The dysembrioplastic neuroepithelial tumor (DNT) is a benign and slow‐growing temporal lobe cortical lesion that presents with clinically unresponsive partial…”
Get full text
Journal Article -
9
Extreme bipolar androgen therapy with darolutamide and testosterone cypionate in patients with metastatic castration-resistant prostate cancer: ExBAT (LACOG 0620) trial
Published in Journal of clinical oncology (20-02-2023)“…TPS276 Background: Prostate cancer has an intrinsic dependence on androgens and androgen receptor (AR) regulation. Suppression of gonadal androgen synthesis…”
Get full text
Journal Article -
10